INVAGESIC Drug Patent Profile
✉ Email this page to a colleague
When do Invagesic patents expire, and what generic alternatives are available?
Invagesic is a drug marketed by Sandoz and is included in one NDA.
The generic ingredient in INVAGESIC is aspirin; caffeine; orphenadrine citrate. There are twenty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; caffeine; orphenadrine citrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INVAGESIC?
- What are the global sales for INVAGESIC?
- What is Average Wholesale Price for INVAGESIC?
Summary for INVAGESIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 31 |
| Patent Applications: | 3,355 |
| DailyMed Link: | INVAGESIC at DailyMed |
US Patents and Regulatory Information for INVAGESIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | INVAGESIC | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074817-001 | Nov 27, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sandoz | INVAGESIC FORTE | aspirin; caffeine; orphenadrine citrate | TABLET;ORAL | 074817-002 | Nov 27, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
